| MDL | MFCD01466199 |
|---|---|
| Molecular Weight | 333.41 |
| Molecular Formula | C19H15N3OS |
| SMILES | OC1=C(N=CC=C2)C2=CC=C1C(NC3=CC=CC=N3)C4=CC=CS4 |
|
Mcl-1 |
IMB-XH1 (Compound 2) is a Mcl-1 inhibitor [1] . IMB-XH is screened out with the IC 50 value of 0.4637 μM at the concentration of 20 μg/mL. IMB-XH1 (20 μg/mL) can increase the sensitivity of E. coli BL21 (DE3) (pET-30a(+)-NDM-1) to ampicillinby more than 8 times. IMB-XHI may have a broad spectrum of metallo-β-lactamases (MBLs) inhibitory activity. The combination of IMB-XH1 and Meropenem (MEM) may have potentials to treat infections caused by metallo-β-lactamases-positive, carbapenem-resistant Gram-negative pathogens [2] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Solid
Room temperature in continental US; may vary elsewhere.
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
DMSO : 33.33 mg/mL ( 99.97 mM ; Need ultrasonic)
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 2.9993 mL | 14.9966 mL | 29.9931 mL |
| 5 mM | 0.5999 mL | 2.9993 mL | 5.9986 mL |
| 10 mM | 0.2999 mL | 1.4997 mL | 2.9993 mL |